| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Sep 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.02B | 5.18B | 5.54B | 7.04B | 7.49B | 9.28B |
| Gross Profit | 2.15B | 5.11B | 2.17B | 2.76B | 2.98B | 3.34B |
| EBITDA | 3.71B | 3.97B | 2.87B | 2.24B | 2.39B | 1.81B |
| Net Income | 3.50B | 3.19B | 2.17B | 1.61B | 1.76B | 1.30B |
Balance Sheet | ||||||
| Total Assets | 53.51B | 49.56B | 56.83B | 65.25B | 76.34B | 95.16B |
| Cash, Cash Equivalents and Short-Term Investments | 9.88B | 10.42B | 12.97B | 15.05B | 5.90B | 11.76B |
| Total Debt | 22.77B | 17.68B | 28.61B | 39.26B | 51.22B | 71.21B |
| Total Liabilities | 23.73B | 18.77B | 29.28B | 39.86B | 51.92B | 72.52B |
| Stockholders Equity | 29.78B | 30.80B | 27.54B | 25.39B | 24.43B | 22.64B |
Cash Flow | ||||||
| Free Cash Flow | 11.66B | 2.20B | 11.36B | 25.62B | 18.87B | 27.20B |
| Operating Cash Flow | 11.66B | 2.20B | 11.39B | 25.63B | 18.87B | 27.21B |
| Investing Cash Flow | -10.83B | 1.70B | 7.76B | -6.89B | 2.59B | -1.54B |
| Financing Cash Flow | -7.22B | -10.91B | -13.83B | -16.69B | -24.59B | -27.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ₹1.42T | 4.84 | ― | 4.62% | 5.79% | 12.66% | |
65 Neutral | ₹19.28B | 4.83 | ― | ― | -18.77% | 47.18% | |
62 Neutral | ₹355.93B | 16.79 | ― | ― | 29.45% | 19.37% | |
62 Neutral | ₹876.60B | 6.35 | ― | 5.56% | 5.53% | 2.67% | |
61 Neutral | ₹690.50B | 18.65 | ― | 0.91% | 10.78% | 12.42% | |
59 Neutral | ₹165.19B | 239.40 | ― | ― | 3.40% | 6.97% |